BAX and breast carcinoma: JNK and p38 MAPK leads to increased Bax translocation from the cytosol to the mitochondria in breast cancer cells [88] and an ectopic expression of the catalytically inactive JNK kinase 2 mutant significantly suppresses the BITC medicated conformational change of Bax [88].